NYSE$SLQT
Selectquote Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
SelectQuote reported Q4 fiscal 2025 revenue of $345.1 million and net income of $12.9 million.
SelectQuote delivered consolidated revenue of $345.1 million in Q4 FY2025, up from $307.2 million in the prior year, with net income of $12.9 million versus a $31.0 million loss last year. The Healthcare Services segment drove growth with $214.0 million in revenue, while Senior segment revenue declined to $82.5 million. The company provided FY2026 guidance of $1.650-$1.750 billion in revenue and $120-$150 million in Adjusted EBITDA.
- Q4 revenue reached $345.1 million, a 12% increase year-over-year.
- Net income turned positive at $12.9 million compared to a $31.0 million loss in Q4 FY2024.
- Healthcare Services revenue grew 47% to $214.0 million with 108,018 SelectRx members.
- FY2026 guidance projects revenue of $1.650-$1.750 billion and Adjusted EBITDA of $120-$150 million.
Headline financials
Revenue & EPS history
SelectQuote · Revenue · Quarterly
$345M
Revenue by segment
SelectQuote · $344M total across 3 segments · Q4 2025
- Healthcare Services$214M—62.1%
- Senior$82.5M—23.9%
- Life$48M—13.9%
Forward guidance
FY2026 revenue expected between $1.650 billion and $1.750 billion with Adjusted EBITDA between $120 million and $150 million.
Tailwinds
- Continued growth in Healthcare Services segment
- Strong SelectRx membership expansion
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
-1.0%
Avg return
Earnings day
+2.3%
Avg return
5 days after
+2.5%
Avg return
30 days after
58%
18 / 31 earnings
Positive
+75.5%
Q2 2023
Best reaction
-49.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -8.9% | +39.9% | +24.3% | |
| Q2 2026 | -29.0% | -37.4% | -47.9% | |
| Q1 2026 | +0.0% | -16.8% | -29.3% | |
| Q4 2025 | +41.5% | +37.2% | +12.0% | |
| Q3 2025 | -12.1% | -14.2% | -15.4% | |
| Q2 2025 | +30.8% | +37.0% | -17.4% | |
| Q1 2025 | +6.9% | +16.7% | +46.1% | |
| Q4 2024 | -49.0% | -44.6% | -37.6% | |
| Q3 2024 | +4.8% | +12.4% | +13.2% | |
| Q2 2024 | +6.3% | +40.5% | +64.0% | |
| Q1 2024 | -4.3% | -5.8% | -3.6% | |
| Q4 2023 | -16.2% | -16.9% | -8.8% | |
| Q3 2023 | +11.1% | -16.7% | +16.7% | |
| Q2 2023 | +75.5% | +128.8% | +181.1% | |
| Q1 2023 | +9.5% | +9.2% | +17.7% | |
| Q4 2022 | -30.4% | -47.5% | -54.9% | |
| Q3 2022 | +7.5% | +0.4% | +20.4% | |
| Q2 2022 | -48.0% | -55.4% | -60.1% | |
| Q1 2022 | -22.3% | -17.8% | -36.3% | |
| Q4 2021 | -44.6% | -37.6% | -7.2% | |
| Q3 2020 | -21.5% | -22.2% | -23.4% | |
| Q3 2021 | -21.9% | -23.2% | -26.6% | |
| Q2 2020 | +7.7% | +9.2% | +7.4% | |
| Q2 2021 | +7.7% | +9.2% | +7.4% | |
| Q1 2020 | +2.7% | +7.7% | +20.3% | |
| Q1 2021 | +7.6% | +10.5% | +23.0% | |
| Q4 2018 | +10.9% | +12.0% | -2.1% | |
| Q4 2019 | +10.9% | +12.0% | -2.1% | |
| Q3 2019 | +10.9% | +12.0% | -2.1% | |
| Q2 2019 | +10.9% | +12.0% | -2.1% | |
| Q4 2020 | +14.2% | +20.1% | +0.3% | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro